NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

癌症診斷市場 - 預測,各地區、主要國家的市場分析,主要企業,COVID-19復甦情境:2021年∼2031年

Cancer Diagnostics Market Report 2021-2031: Forecasts by Test Type, Imaging, Biopsy, by Cancer Type, by End-user, Regional & Leading National Market Analysis, Leading Cancer Diagnostic Companies, COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 1013620
出版日期 內容資訊 英文 599 Pages
商品交期: 最快1-2個工作天內
價格
癌症診斷市場 - 預測,各地區、主要國家的市場分析,主要企業,COVID-19復甦情境:2021年∼2031年 Cancer Diagnostics Market Report 2021-2031: Forecasts by Test Type, Imaging, Biopsy, by Cancer Type, by End-user, Regional & Leading National Market Analysis, Leading Cancer Diagnostic Companies, COVID-19 Recovery Scenarios
出版日期: 2021年04月14日內容資訊: 英文 599 Pages
簡介

癌症診斷產業,為了活用未開發的市場機會,進行開發新檢驗法的大規模投資。例如,VolitionRx Limited在歐洲發布了其Nu.Q結直腸癌分類測試。同樣,新DetermaIO的開發商OncoCyte Corporation 預計將於2021年2月在美國推出,這是一種三陰性乳腺癌(TNBC)和非小細胞肺癌 (NSCLC) 新輔助控制點抑製劑反應的生物標誌物。預計所有這些因素都將為預測期內的癌症診斷市場參與者提供有利的成長機會。

本報告提供全球癌症診斷市場相關調查分析,市場動態,各市場區隔的市場分析,各地區、主要國家的市場分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場動態

  • 促進因素
  • 阻礙因素
  • 市場機會
  • SWOT分析
  • 產業分析 - 波特的五力分析
  • 產業分析 - PEST分析

第4章 癌症診斷市場:各檢驗類型

  • 腫瘤生物標記檢驗
  • 成像
  • 活體組織切片
  • 液態切片
  • 免疫組織化學
  • 原位 雜合反應

第5章 癌症診斷市場:癌症的各類型

  • 乳癌
  • 肺癌症
  • 大腸癌症
  • 黑色素瘤
  • 血液癌症
  • 前列腺癌症
  • 卵巢癌症
  • 胃癌
  • 肝臟癌症
  • 其他

第6章 癌症診斷市場:各終端用戶

  • 醫院相關實驗室
  • 獨立型臨床檢驗室
  • 影像診斷中心
  • 癌症研究機關
  • 其他

第7章 各地區、主要國家的癌症診斷市場預測

  • 全球癌症診斷市場預測:各地區
  • COVID-19的影響的復甦情境(V,U,W,L)

第8章 北美的癌症診斷市場

  • 全球癌症診斷市場上北美優勢
  • 北美的癌症診斷市場預測:各國
  • 北美的癌症診斷市場預測:各檢驗類型
  • 北美的癌症診斷市場預測:癌症的各類型
  • 北美的癌症診斷市場預測:各終端用戶
  • 美國的癌症診斷市場預測
  • 加拿大的癌症診斷市場預測

第9章 歐洲的癌症診斷市場

第10章 亞太地區 (日本以外)的癌症診斷市場

第11章 日本的癌症診斷市場

第12章 南美的癌症診斷市場

第13章 中東、非洲的癌症診斷市場

第14章 企業簡介

  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Siemens AG
  • Bio Rad Laboratories Inc.
  • GE Healthcare
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Agilent Technologies, Inc.
  • Quest Diagnostics
  • Genomic Health (Exact Sciences Corporation)
  • BioMark Diagnostics Inc.
  • Hologic, Inc.
  • Abbott
  • BD
  • QIAGEN

第15章 結論與建議

目錄
Product Code: PHA1126

Title:
Cancer Diagnostics Market Report 2021-2031
Forecasts by Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, BRCA Tests, CA-19 Tests, CEA Tests, HER2 Tests, KRAS Mutation Tests, ALK Tests, EGFR Mutation Tests, Others), Imaging (Mammography, Ultrasound, PET Scan, MRI Scan, CT Scan, SPECT & Others), Biopsy (Endoscopic Biopsy, Needle Biopsy, Bone Marrow Biopsy, Others), Immunohistochemistry, Liquid Biopsy, In Situ Hybridization), by Cancer Type (Lung Cancer, Melanoma, Breast Cancer, Colorectal Cancer, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others), by End-user (Hospital Associated Labs, Diagnostic Imaging Centers, Independent Diagnostic Laboratories, Cancer Research Institutes, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cancer Diagnostics Companies AND COVID-19 Recovery Scenarios.

Cancer Diagnostics Market- Our new study reveals trends, R&D progress, and predicted revenues over the next decade

Growing Demand for Non-Invasive Cancer Diagnosis

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market. For instance, VolitionRx Limited, released its Nu.Q colorectal cancer triage test in Europe. Similarly, OncoCyte Corporation, developer of the new DetermaIO, a biomarker of triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) neoadjuvant control point inhibitor response, is expected to be launched in the US by 2H2021. All these factors are anticipated to offer lucrative growth opportunities for the cancer diagnostics market players over the forecast period.

North America Currently Dominates the Global Cancer Diagnostics Market

Based on regions, the global cancer diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to Visiongain analysis, North America cancer diagnostics accounted for majority of the market share and is projected to witness significant growth over the forecast period from 2021 to 2031. The growth is attributed to rising cancer burden which is influenced by many factors, such as aging populations and shift in lifestyle patterns. Patients are encouraged to use healthcare facilities by enhancing compensation. Various cancer prevention programs are organized by government agencies (such as the Colorectal Cancer Control Program) to increase the cancer screening among men & women aged 50 years and above.

How are prominent players reinforcing their position across the global business?

Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies. See where the expected gains will be. View Visiongain's assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of leading companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and outlook.

Discover how to stay ahead

Our 590+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cancer Diagnostics Market. See how to exploit the opportunities.

Cancer Diagnostics Market Segmentation

Test Type

  • Tumor Biomarkers Tests
  • PSA Tests
  • CTC Tests
  • AFP Tests
  • CA-19 Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • CEA Tests
  • EGFR Mutation Tests
  • KRAS Mutation Tests
  • Others
  • Imaging
  • Ultrasound
  • Mammography
  • MRI Scan
  • PET Scan
  • CT Scan
  • SPECT & Others
  • Biopsy
  • Needle Biopsy
  • Endoscopic Biopsy
  • Bone Marrow Biopsy
  • Others
  • Liquid Biopsy
  • Immunohistochemistry
  • In Situ Hybridization

Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Blood Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Stomach Cancer
  • Liver Cancer
  • Others

End-User

  • Hospital Associated Labs
  • Independent Diagnostic Laboratories
  • Diagnostic Imaging Centers
  • Cancer Research Institutes
  • Other End-Users

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Poland
    • Rest of Europe
  • Japan
  • Asia Pacific Excluding Japan
    • China
    • Australia
    • India
    • Singapore
    • South Korea
    • Thailand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

COVID-19 Impact Recovery Scenarios

This report includes Baseline Forecasts along with Different Rebound Scenarios to help analyze the global Cancer Diagnostics market-no matter how COVID-19 affects the economy.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.

Leading countries and the potential for market growth

Overall world revenue for cancer diagnostics market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Cancer Diagnostics Market report helps you

In summary, our 590+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Cancer Diagnostics Market, with forecasts for production process, application, product, and material, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 21 key national markets- See forecasts for the Cancer Diagnostics market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Also forecasted is the market in the US, Canada, Germany, UK, France, Italy, Russia, Japan, China, India, Australia, Brazil, Mexico, GCC, and South Africa among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 16 of the major companies involved in the Cancer Diagnostics Market. Some of the companies profiled in this report are Abbott, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens AG, Bio Rad Laboratories Inc., GE Healthcare, Illumina, Inc., Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Agilent Technologies, Inc., Quest Diagnostics, Genomic Health (Exact Sciences Corporation), BioMark Diagnostics Inc., Hologic, Inc., QIAGEN, and BD among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Cancer Diagnostics Market and leading companies. You will find data, trends, and predictions.

Who should read this report?

  • Senior Executives
  • Business Development Managers
  • Marketing Directors
  • Consultants
  • Chief Executive Officers
  • Governments, agencies & organizations actively working or interested in the Cancer Diagnostics industry will also find significant value in our research.

Customization Available: Global Cancer Diagnostics Market

  • Do you have any custom requirements we can help you with?
  • Any specific country, geography, country, market segment or specific company information?

Buy our report today“ Cancer Diagnostics Market Report 2021-2031: Forecasts by Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, BRCA Tests, CA-19 Tests, CEA Tests, HER2 Tests, KRAS Mutation Tests, ALK Tests, EGFR Mutation Tests, Others), Imaging (Mammography, Ultrasound, PET Scan, MRI Scan, CT Scan, SPECT & Others), Biopsy (Endoscopic Biopsy, Needle Biopsy, Bone Marrow Biopsy, Others), Immunohistochemistry, Liquid Biopsy, In Situ Hybridization), by Cancer Type (Lung Cancer, Melanoma, Breast Cancer, Colorectal Cancer, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others), by End-user (Hospital Associated Labs, Diagnostic Imaging Centers, Independent Diagnostic Laboratories, Cancer Research Institutes, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cancer Diagnostics Companies AND COVID-19 Recovery Scenarios. ” Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Cancer Diagnostics Market
  • 1.2 Why You Should Read This Report
  • 1.3 What This Report Delivers
  • 1.4 Key Questions Answered By This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 COVID-19 Impact: Recovery Scenarios
    • 1.6.2 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2 Executive Summary

3 Market Dynamics

  • 3.1 Drivers
    • 3.1.1 Inclusion of Cancer Screening Tests in National Screening Programs
    • 3.1.2 Rising Funding for Cancer Research to Augur Growth
    • 3.1.3 Advances in Imaging Techniques
    • 3.1.4 Growing Demand for Non-Invasive Cancer Diagnosis
    • 3.1.5 Rising Prevalence of Cancer to Boost Cancer Diagnostic Market
    • 3.1.6 Rising Ageing Population Across Emerging Economies to Fuel Cancer Diagnostics Market
  • 3.2 Restraints
    • 3.2.1 Insurance Coverage & Reimbursement Issues
    • 3.2.2 High Research and Development Investment to Hamper Market Growth
    • 3.2.3 Lack of Awareness to Restrain Cancer Diagnostics Market Growth
  • 3.3 Opportunities
    • 3.3.1 Personalized Medicine for Cancer to Offer Lucrative Growth Opportunities
    • 3.3.2 Integration of Artificial Intelligence in Cancer Therapy
    • 3.3.3 Advent of Nano Formulations in Cancer Management
  • 3.4 SWOT Analysis
    • 3.4.1 Strengths
    • 3.4.2 Weaknesses
    • 3.4.3 Opportunities
    • 3.4.4 Threats
  • 3.5 Industry analysis - Porter's
    • 3.5.1 Buyer Power
    • 3.5.2 Supplier Power
    • 3.5.3 Competitive Rivalry
    • 3.5.4 Threat of Substitute
    • 3.5.5 Threat of New Entrants
  • 3.6 Industry analysis - PEST Analysis
    • 3.6.1 Political Factors Impacting Cancer Diagnostics Market
    • 3.6.2 Economic Factors Impacting Cancer Diagnostics Market
    • 3.6.3 Social Factors Impacting Cancer Diagnostics Market
    • 3.6.4 Technological Factors Impacting Cancer Diagnostics Market

4 Cancer Diagnostics Market by Test Type

  • 4.1 Tumor Biomarkers Tests Segment Market Forecast, 2021-2031
    • 4.1.1 Technological Advancements to fuel Tumor Biomarkers Segment
    • 4.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.2 Imaging Segment Market Forecast, 2021-2031
    • 4.2.1 Growing Demand for Early & Accurate Diagnosis to Augur Growth
    • 4.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.3 Biopsy Segment Market Forecast, 2021-2031
    • 4.3.1 Increasing R&D Funding to Fuel Segment Growth
    • 4.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.4 Liquid Biopsy Segment Market Forecast, 2021-2031
    • 4.4.1 Increasing Preference of Non-Invasive Procedures to Fuel Segment Growth
    • 4.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.5 Immunohistochemistry Segment Market Forecast, 2021-2031
    • 4.5.1 Launch of advanced IHC solutions
    • 4.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 4.6 In Situ Hybridization Segment Market Forecast, 2021-2031
    • 4.6.1 Rising penetration of companion diagnostics for cancer detection
    • 4.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

5 Cancer Diagnostics Market by Cancer Type

  • 5.1 Breast Cancer Segment Market Forecast, 2021-2031
    • 5.1.1 Breast cancer being most diagnosed cancer among the worlds
    • 5.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.2 Lung Cancer Segment Market Forecast, 2021-2031
    • 5.2.1 Trend of smoking in teenagers to propel segment growth
    • 5.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.3 Colorectal Cancer Segment Market Forecast, 2021-2031
    • 5.3.1 Genetic factors to play an important role in prevalence of colorectal cancer
    • 5.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.4 Melanoma Segment Market Forecast, 2021-2031
    • 5.4.1 Strong emerging pipeline to increase the survival rate which in turn likely to propel growth
    • 5.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.5 Blood Cancer Segment Market Forecast, 2021-2031
    • 5.5.1 Early detection due to DNA tests to mark significant growth in segment revenue
    • 5.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.6 Prostate Cancer Segment Market Forecast, 2021-2031
    • 5.6.1 Implementation of AI for detection to increase diagnosis rates of prostate cancer
    • 5.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.7 Ovarian Cancer Segment Market Forecast, 2021-2031
    • 5.7.1 Rising funding for cancer research to propel growth
    • 5.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.8 Stomach Cancer Segment Market Forecast, 2021-2031
    • 5.8.1 Unhealthy diet to increase chances of stomach cancer further growing diagnosis for the same
    • 5.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.9 Liver Cancer Segment Market Forecast, 2021-2031
    • 5.9.1 Alcoholism being a major factor in increasing number of liver cancer patients
    • 5.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 5.10 Others Segment Market Forecast, 2021-2031
    • 5.10.1 COVID-19 Impact Recovery Scenarios (V, U, W, L)

6 Cancer Diagnostics Market by End-User

  • 6.1 Hospital Associated Labs Segment Market Forecast, 2021-2031
    • 6.1.1 Expansion of hospital chains to increase the number of associated labs
    • 6.1.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.2 Independent Diagnostic Laboratories Segment Market Forecast, 2021-2031
    • 6.2.1 Availability of high-tech screening instruments to propel growth of the segment
    • 6.2.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.3 Diagnostic Imaging Centers Segment Market Forecast, 2021-2031
    • 6.3.1 Large number of imaging centers in developing countries to increase market share
    • 6.3.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.4 Cancer Research Institutes Segment Market Forecast, 2021-2031
    • 6.4.1 Continuous R&D and funded programs is likely to increase segment revenues
    • 6.4.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)
  • 6.5 Other End-Users Segment Market Forecast, 2021-2031
    • 6.5.1 Cause driven screening camps to propel segment growth
    • 6.5.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

7 Regional and Leading National Cancer Diagnostics Market Forecasts 2021-2031

  • 7.1 Global Cancer Diagnostics Market by Region Forecast 2021-2031
  • 7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L)

8 North America Cancer Diagnostics Market, 2021-2031

  • 8.1 North America Dominates the Worldwide Cancer Diagnostics Market
  • 8.2 North America Cancer Diagnostics Market by Country, Forecast 2021-2031
  • 8.3 North America Cancer Diagnostics Market Forecast by Test Type
    • 8.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031
  • 8.4 North America Cancer Diagnostics Market Forecast by Cancer Type
    • 8.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
  • 8.5 North America Cancer Diagnostics Market Forecast by End-User
    • 8.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): North America Cancer Diagnostics Market Forecast by End-User, 2021-2031
  • 8.6 U.S. Cancer Diagnostics Market Forecast, 2021-2031
    • 8.6.1 Large population base and top-notch medical infrastructure to support market expansion
    • 8.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): U.S. Cancer Diagnostics Market Forecast, 2021-2031
  • 8.7 Canada Cancer Diagnostics Market Forecast, 2021-2031
    • 8.7.1 Improving diagnosis rates to favour lucrative market growth
    • 8.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Canada Cancer Diagnostics Market Forecast, 2021-2031

9 Europe Cancer Diagnostics Market, 2021-2031

  • 9.1 Presence of highly developed MedTech infrastructure to propel cancer diagnosis within the region
  • 9.2 Europe Cancer Diagnostics Market by Country, Forecast 2021-2031
  • 9.3 Europe Cancer Diagnostics Market Forecast by Test Type
    • 9.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031
  • 9.4 Europe Cancer Diagnostics Market Forecast by Cancer Type
    • 9.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
  • 9.5 Europe Cancer Diagnostics Market Forecast by End-User
    • 9.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031
  • 9.6 Germany Cancer Diagnostics Market Forecast, 2021-2031
    • 9.6.1 Rising healthcare spending and positive healthcare reforms towards cancer screening
    • 9.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Germany Cancer Diagnostics Market Forecast, 2021-2031
  • 9.7 UK Cancer Diagnostics Market Forecast, 2021-2031
    • 9.7.1 Rising incidence of all cancers to propel market expansion
    • 9.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): UK Cancer Diagnostics Market Forecast, 2021-2031
  • 9.8 France Cancer Diagnostics Market Forecast, 2021-2031
    • 9.8.1 Large number of smokers to create a potential candidate for lung cancer screening
    • 9.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): France Cancer Diagnostics Market Forecast, 2021-2031
  • 9.9 Italy Cancer Diagnostics Market Forecast, 2021-2031
    • 9.9.1 Growing prevalence of prostate cancer to expand market revenues
    • 9.9.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Italy Cancer Diagnostics Market Forecast, 2021-2031
  • 9.10 Spain Cancer Diagnostics Market Forecast, 2021-2031
    • 9.10.1 Presence of advanced screening centres to propel market growth
    • 9.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Spain Cancer Diagnostics Market Forecast, 2021-2031
  • 9.11 Russia Cancer Diagnostics Market Forecast, 2021-2031
    • 9.11.1 Developing healthcare facilities to increase the demand for cancer screening products
    • 9.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Russia Cancer Diagnostics Market Forecast, 2021-2031
  • 9.12 Poland Cancer Diagnostics Market Forecast, 2021-2031
    • 9.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Poland Cancer Diagnostics Market Forecast, 2021-2031
  • 9.13 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031
    • 9.13.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031

10 APEJ Cancer Diagnostics Market, 2021-2031

  • 10.1 Rising cases in India and China to increase the regional market
  • 10.2 APEJ Cancer Diagnostics Market by Country, Forecast 2021-2031
  • 10.3 APEJ Cancer Diagnostics Market Forecast by Test Type
    • 10.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031
  • 10.4 APEJ Cancer Diagnostics Market Forecast by Cancer Type
    • 10.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
  • 10.5 APEJ Cancer Diagnostics Market Forecast by End-User
    • 10.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031
  • 10.6 China Cancer Diagnostics Market Forecast, 2021-2031
    • 10.6.1 Large population and well-established healthcare infrastructure to increase market revenues
    • 10.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): China Cancer Diagnostics Market Forecast, 2021-2031
  • 10.7 Australia Cancer Diagnostics Market Forecast, 2021-2031
    • 10.7.1 Positive government initiatives to propel regional market growth
    • 10.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Australia Cancer Diagnostics Market Forecast, 2021-2031
  • 10.8 India Cancer Diagnostics Market Forecast, 2021-2031
    • 10.8.1 Government funding's and healthcare reforms to propel market revenues
    • 10.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): India Cancer Diagnostics Market Forecast, 2021-2031
  • 10.9 Singapore Cancer Diagnostics Market Forecast, 2021-2031
    • 10.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Singapore Cancer Diagnostics Market Forecast, 2021-2031
  • 10.10 South Korea Cancer Diagnostics Market Forecast, 2021-2031
    • 10.10.1 Positive government policies likely to improve market for cancer diagnostics
    • 10.10.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Korea Cancer Diagnostics Market Forecast, 2021-2031
  • 10.11 Thailand Cancer Diagnostics Market Forecast, 2021-2031
    • 10.11.1 Medical tourism to support cancer diagnostics market in Thailand
    • 10.11.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Thailand Cancer Diagnostics Market Forecast, 2021-2031
  • 10.12 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031
    • 10.12.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031

11 Japan Cancer Diagnostics Market, 2021-2031

  • 11.1 Rising geriatric population susceptible to pancreatic caner to increase market growth
  • 11.2 Japan Cancer Diagnostics Market Forecast by Test Type
    • 11.2.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031
  • 11.3 Japan Cancer Diagnostics Market Forecast by Cancer Type
    • 11.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
  • 11.4 Japan Cancer Diagnostics Market Forecast by End-User
    • 11.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031
  • 11.5 Japan Cancer Diagnostics Market Forecast, 2021-2031
    • 11.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Japan Cancer Diagnostics Market Forecast, 2021-2031

12 Latin America Cancer Diagnostics Market, 2021-2031

  • 12.1 Cost effective healthcare compared to North America to attract more revenues
  • 12.2 Latin America Cancer Diagnostics Market by Country, Forecast 2021-2031
  • 12.3 Latin America Cancer Diagnostics Market Forecast by Test Type
    • 12.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031
  • 12.4 Latin America Cancer Diagnostics Market Forecast by Cancer Type
    • 12.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
  • 12.5 Latin America Cancer Diagnostics Market Forecast by End-User
    • 12.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031
  • 12.6 Brazil Cancer Diagnostics Market Forecast, 2021-2031
    • 12.6.1 High prevalence rate among middle income groups to increase market for cancer diagnostics
    • 12.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Brazil Cancer Diagnostics Market Forecast, 2021-2031
  • 12.7 Mexico Cancer Diagnostics Market Forecast, 2021-2031
    • 12.7.1 Medical tourism to increase revenues for cancer diagnostics
    • 12.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Mexico Cancer Diagnostics Market Forecast, 2021-2031
  • 12.8 Argentina Cancer Diagnostics Market Forecast, 2021-2031
    • 12.8.1 Rising incidence rates to increase revenues from cancer diagnostics
    • 12.8.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): Argentina Cancer Diagnostics Market Forecast, 2021-2031
  • 12.9 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031
    • 12.9.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031

13 MEA Cancer Diagnostics Market, 2021-2031

  • 13.1 Improving healthcare infrastructure to propel regional growth
  • 13.2 MEA Cancer Diagnostics Market by Country, Forecast 2021-2031
  • 13.3 MEA Cancer Diagnostics Market Forecast by Test Type
    • 13.3.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031
  • 13.4 MEA Cancer Diagnostics Market Forecast by Cancer Type
    • 13.4.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031
  • 13.5 MEA Cancer Diagnostics Market Forecast by End-User
    • 13.5.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031
  • 13.6 GCC Cancer Diagnostics Market Forecast, 2021-2031
    • 13.6.1 Higher healthcare spending compared to regional counterparts to increase market revenues in future
    • 13.6.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): GCC Cancer Diagnostics Market Forecast, 2021-2031
  • 13.7 South Africa Cancer Diagnostics Market Forecast, 2021-2031
    • 13.7.1 Increasing R&D within the country to expand avenues for cancer diagnostics in south Africa
    • 13.7.2 COVID-19 Impact Recovery Scenarios (V, U, W, L): South Africa Cancer Diagnostics Market Forecast, 2021-2031
  • 13.8 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031
    • 13.8.1 COVID-19 Impact Recovery Scenarios (V, U, W, L): Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031

14 Company Profiles

  • 14.1 F. Hoffmann-La Roche Ltd.
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis
    • 14.1.4 Product Benchmarking
    • 14.1.5 Recent Developments
    • 14.1.6 SWOT Analysis
  • 14.2 Thermo Fisher Scientific Inc.
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
    • 14.2.4 Product Benchmarking
    • 14.2.5 Recent Developments
    • 14.2.6 SWOT Analysis
  • 14.3 Siemens AG
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
    • 14.3.4 Product Benchmarking
    • 14.3.5 Recent Developments
    • 14.3.6 SWOT Analysis
  • 14.4 Bio Rad Laboratories Inc.
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
    • 14.4.4 Product Benchmarking
    • 14.4.5 Recent Developments
    • 14.4.6 SWOT Analysis
  • 14.5 GE Healthcare
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
    • 14.5.4 Product Benchmarking
    • 14.5.5 Recent Developments
    • 14.5.6 SWOT Analysis
  • 14.6 Illumina, Inc.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
    • 14.6.4 Product Benchmarking
    • 14.6.5 Recent Developments
    • 14.6.6 SWOT Analysis
  • 14.7 Koninklijke Philips N.V.
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
    • 14.7.4 Product Benchmarking
    • 14.7.5 Recent Developments
    • 14.7.6 SWOT Analysis
  • 14.8 Canon Medical Systems Corporation
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
    • 14.8.4 Product Benchmarking
    • 14.8.5 Recent Developments
  • 14.9 Agilent Technologies, Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
    • 14.9.4 Product Benchmarking
    • 14.9.5 Recent Developments
    • 14.9.6 SWOT Analysis
  • 14.10 Quest Diagnostics
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
    • 14.10.4 Product Benchmarking
    • 14.10.5 Recent Developments
    • 14.10.6 SWOT Analysis
  • 14.11 Genomic Health (Exact Sciences Corporation)
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
    • 14.11.4 Product Benchmarking
  • 14.12 BioMark Diagnostics Inc.
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
    • 14.12.4 Product Benchmarking
    • 14.12.5 Recent Developments
  • 14.13 Hologic, Inc.
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
    • 14.13.4 Product Benchmarking
  • 14.14 Abbott
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
    • 14.14.4 Product Benchmarking
    • 14.14.5 SWOT Analysis
  • 14.15 BD
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
    • 14.15.4 Product Benchmarking
    • 14.15.5 Recent Developments
  • 14.16 QIAGEN
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
    • 14.16.4 Product Benchmarking

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks
  • 15.2 Recommendations

List of Tables

  • Table 1 Global Cancer Diagnostics Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
  • Table 2 Global Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 3 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 4 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 5 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 6 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 7 Global Cancer Diagnostics Market Forecast by Tumor Biomarkers Tests, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 8 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 9 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 10 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 11 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 12 Global Cancer Diagnostics Market Forecast by Imaging, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 13 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 14 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 15 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 16 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 17 Global Cancer Diagnostics Market Forecast by Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 18 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 19 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 20 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 21 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 22 Cancer Diagnostics Market Forecast for Liquid Biopsy, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 23 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 24 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 25 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 26 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 27 Cancer Diagnostics Market Forecast for Immunohistochemistry, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 28 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 29 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 30 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 31 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 32 Cancer Diagnostics Market Forecast for In Situ Hybridization, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 33 Global Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 34 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 35 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 36 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 37 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 38 Cancer Diagnostics Market Forecast for Breast Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 39 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 40 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 41 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 42 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 43 Cancer Diagnostics Market Forecast for Lung Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 44 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 45 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 46 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 47 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 48 Cancer Diagnostics Market Forecast for Colorectal Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 49 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 50 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 51 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 52 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 53 Cancer Diagnostics Market Forecast for Melanoma, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 54 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 55 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 56 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 57 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 58 Cancer Diagnostics Market Forecast for Blood Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 59 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 60 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 61 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 62 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 63 Cancer Diagnostics Market Forecast for Prostate Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 64 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 65 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 66 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 67 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 68 Cancer Diagnostics Market Forecast for Ovarian Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 69 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 70 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 71 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 72 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 73 Cancer Diagnostics Market Forecast for Stomach Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 74 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 75 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 76 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 77 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 78 Cancer Diagnostics Market Forecast for Liver Cancer, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 79 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 80 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 81 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 82 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 83 Cancer Diagnostics Market Forecast for Other Cancers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 84 Global Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 85 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 86 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 87 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 88 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 89 Cancer Diagnostics Market Forecast for Hospital Associated Labs, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 90 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 91 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 92 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 93 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 94 Cancer Diagnostics Market Forecast for Independent Diagnostic Laboratories, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 95 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 96 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 97 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 98 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 99 Cancer Diagnostics Market Forecast for Diagnostic Imaging Centers, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 100 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 101 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 102 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 103 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 104 Cancer Diagnostics Market Forecast for Cancer Research Institutes, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 105 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 106 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 107 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 108 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 109 Cancer Diagnostics Market Forecast for Other End-Users, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 110 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 111 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 112 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 113 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 114 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 115 North America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 116 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 117 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 118 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 119 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 120 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 121 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 122 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 123 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 124 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 125 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 126 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 127 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 128 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 129 North America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 130 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 131 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 132 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 133 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 134 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 135 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 136 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 137 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 138 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 139 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 140 Europe Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 141 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 142 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 143 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 144 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 145 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 146 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 147 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 148 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 149 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 150 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 151 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 152 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 153 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 154 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 155 Europe Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 156 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 157 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 158 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 159 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 160 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 161 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 162 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 163 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 164 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 165 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 166 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 167 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 168 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 169 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 170 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 171 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 172 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 173 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 174 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 175 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 176 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 177 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 178 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 179 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 180 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 181 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 182 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 183 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 184 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 185 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 186 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 187 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 188 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 189 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 190 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 191 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 192 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 193 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 194 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 195 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 196 APEJ Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 197 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 198 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 199 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 200 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 201 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 202 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 203 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 204 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 205 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 206 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 207 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 208 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 209 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 210 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 211 APEJ Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 212 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 213 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 214 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 215 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 216 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 217 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 218 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 219 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 220 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 221 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 222 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 223 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 224 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 225 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 226 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 227 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 228 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 229 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 230 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 231 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 232 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 233 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 234 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 235 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 236 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 237 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 238 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 239 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 240 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 241 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 242 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 243 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 244 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 245 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 246 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 247 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 248 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 249 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 250 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 251 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 252 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 253 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 254 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 255 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 256 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 257 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 258 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 259 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 260 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 261 Japan Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 262 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 263 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 264 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 265 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 266 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 267 Latin America Cancer Diagnostics Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 268 LATAM Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 269 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 270 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 271 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 272 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 273 LATAM Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 274 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 275 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 276 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 277 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 278 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 279 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 280 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 281 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 282 Latin America Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 283 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 284 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 285 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 286 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 287 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 288 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 289 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 290 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 291 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 292 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 293 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 294 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 295 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 296 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 297 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 298 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 299 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 300 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 301 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 302 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 303 MEA Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 304 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 305 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 306 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 307 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 308 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 309 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 310 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 311 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 312 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 313 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 314 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 315 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 316 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 317 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 318 MEA Cancer Diagnostics Market Forecast by End User, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 319 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 320 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 321 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 322 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 323 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 324 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 325 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 326 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 327 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 328 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 329 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 330 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 331 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 332 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 333 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 334 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 335 F. Hoffmann-La Roche Ltd.: Product Benchmarking
  • Table 336 F. Hoffmann-La Roche Ltd.: Recent Developments
  • Table 337 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 338 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 339 Thermo Fisher Scientific Inc.: Recent Developments
  • Table 340 Siemens AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 341 Siemens AG: Product Benchmarking
  • Table 342 Siemens AG: Recent Developments
  • Table 343 Bio Rad Laboratories Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 344 Bio Rad Laboratories Inc.: Product Benchmarking
  • Table 345 Bio Rad Laboratories Inc.: Recent Developments
  • Table 346 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 347 GE Healthcare: Product Benchmarking
  • Table 348 GE Healthcare: Recent Developments
  • Table 349 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 350 Illumina, Inc.: Product Benchmarking
  • Table 351 Illumina, Inc.: Recent Developments
  • Table 352 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 353 Koninklijke Philips N.V.: Product Benchmarking
  • Table 354 Koninklijke Philips N.V.: Recent Developments
  • Table 355 Toshiba Medical Systems Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 356 Canon Medical Systems Corporation: Product Benchmarking
  • Table 357 Canon Medical Systems Corporation: Recent Developments
  • Table 358 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 359 Agilent Technologies, Inc.: Product Benchmarking
  • Table 360 Agilent Technologies, Inc.: Recent Developments
  • Table 361 Quest Diagnostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 362 Quest Diagnostics: Product Benchmarking
  • Table 363 Quest Diagnostics: Recent Developments
  • Table 364 Genomic Health (Exact Sciences Corporation): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 365 Genomic Health (Exact Sciences Corporation): Product Benchmarking
  • Table 366 BioMark Diagnostics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 367 BioMark Diagnostics Inc.: Product Benchmarking
  • Table 368 BioMark Diagnostics Inc.: Recent Developments
  • Table 369 Hologic, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 370 Hologic, Inc.: Product Benchmarking
  • Table 371 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 372 Abbott: Product Benchmarking
  • Table 373 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 374 BD: Product Benchmarking
  • Table 375 BD: Recent Developments
  • Table 376 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 377 QIAGEN: Product Benchmarking

List of Figures

  • Figure 1 Global Cancer Diagnostics Market: Market Segmentation
  • Figure 2 Global Cancer Diagnostics Market: Market Trends
  • Figure 3 Global Cancer Deaths by Age, 2019 (%)
  • Figure 4 Share of population with Cancer, 2019 (%)
  • Figure 5 Ageing Population Estimates 2010 - 2050
  • Figure 6 Global Cancer Diagnostics Market: SWOT Analysis
  • Figure 7 Porter's Analysis
  • Figure 8 PEST Analysis
  • Figure 9 Global Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR %)
  • Figure 10 Global Cancer Diagnostics Market Share Forecast by Test Type, 2021, 2026, 2031 (%)
  • Figure 11 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 12 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 13 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 14 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 15 Global Cancer Diagnostics Market for Tumor Biomarkers Tests Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 16 Global Cancer Diagnostics Market for Imaging Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 17 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 18 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 19 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 20 Global Cancer Diagnostics Market for Imaging Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 21 Global Cancer Diagnostics Market for Biopsy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 22 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 23 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 24 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 25 Global Cancer Diagnostics Market for Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 26 Global Cancer Diagnostics Market for Liquid Biopsy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 27 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 28 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 29 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 30 Global Cancer Diagnostics Market for Liquid Biopsy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 31 Global Cancer Diagnostics Market for Immunohistochemistry Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 32 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 33 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 34 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 35 Global Cancer Diagnostics Market for Immunohistochemistry Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 36 Global Cancer Diagnostics Market for In Situ Hybridization Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 37 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 38 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 39 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 40 Global Cancer Diagnostics Market for In Situ Hybridization Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 41 Global Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR %)
  • Figure 42 Global Cancer Diagnostics Market Share Forecast by Cancer Type, 2021, 2026, 2031 (%)
  • Figure 43 Global Cancer Diagnostics Market for Breast Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 44 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 45 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 46 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 47 Global Cancer Diagnostics Market for Breast Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 48 Global Lung Cancer Statistics, 2020 (Both Sexes)
  • Figure 49 Global Cancer Diagnostics Market for Lung Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 50 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 51 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 52 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 53 Global Cancer Diagnostics Market for Lung Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 54 Global Cancer Diagnostics Market for Colorectal Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 55 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 56 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 57 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 58 Global Cancer Diagnostics Market for Colorectal Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 59 Global Cancer Diagnostics Market for Melanoma Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 60 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 61 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 62 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 63 Global Cancer Diagnostics Market for Melanoma Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 64 Global Cancer Diagnostics Market for Blood Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 65 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 66 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 67 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 68 Global Cancer Diagnostics Market for Blood Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 69 Global Prostate Cancer Statistics, 2020 (Both Sexes)
  • Figure 70 Global Cancer Diagnostics Market for Prostate Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 71 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 72 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 73 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 74 Global Cancer Diagnostics Market for Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 75 Global Cancer Diagnostics Market for Ovarian Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 76 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 77 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 78 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 79 Global Cancer Diagnostics Market for Ovarian Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 80 Global Cancer Diagnostics Market for Stomach Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 81 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 82 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 83 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 84 Global Cancer Diagnostics Market for Stomach Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 85 Global Cancer Diagnostics Market for Liver Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 86 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 87 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 88 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 89 Global Cancer Diagnostics Market for Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 90 Global Cancer Diagnostics Market for Others Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 91 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 92 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 93 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 94 Global Cancer Diagnostics Market for Others Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 95 Global Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR %)
  • Figure 96 Global Cancer Diagnostics Market Share Forecast by End-User, 2021, 2026, 2031 (%)
  • Figure 97 Global Cancer Diagnostics Market for Hospital Associated Labs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 98 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 99 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 100 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 101 Global Cancer Diagnostics Market for Hospital Associated Labs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 102 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 103 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 104 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 105 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 106 Global Cancer Diagnostics Market for Independent Diagnostic Laboratories Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 107 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 108 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 109 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 110 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 111 Global Cancer Diagnostics Market for Diagnostic Imaging Centers Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 112 Global Cancer Diagnostics Market for Cancer Research Institutes Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 113 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 114 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 115 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 116 Global Cancer Diagnostics Market for Cancer Research Institutes Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 117 Global Cancer Diagnostics Market for Other End-Users Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 118 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 119 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 120 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 121 Global Cancer Diagnostics Market for Other End-Users Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 122 Global Cancer Diagnostics Market Forecast by Region 2021-2031 (US$ million)
  • Figure 123 Global Cancer Diagnostics Market Share Forecast by Region 2021, 2026, 2031 (%)
  • Figure 124 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 125 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 126 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 127 Global Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 128 North America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
  • Figure 129 North America Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 130 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
  • Figure 131 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 132 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 133 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 134 North America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 135 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
  • Figure 136 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 137 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 138 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 139 North America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 140 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
  • Figure 141 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 142 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 143 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 144 North America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 145 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 146 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 147 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 148 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 149 U.S. Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 150 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 151 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 152 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 153 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 154 Canada Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 155 Europe Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
  • Figure 156 Europe Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 157 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
  • Figure 158 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 159 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 160 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 161 Europe Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 162 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
  • Figure 163 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 164 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 165 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 166 Europe Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 167 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
  • Figure 168 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 169 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 170 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 171 Europe Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 172 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 173 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 174 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 175 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 176 Germany Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 177 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 178 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 179 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 180 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 181 UK Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 182 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 183 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 184 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 185 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 186 France Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 187 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 188 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 189 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 190 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 191 Italy Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 192 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 193 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 194 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 195 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 196 Spain Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 197 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 198 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 199 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 200 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 201 Russia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 202 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 203 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 204 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 205 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 206 Poland Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 207 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 208 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 209 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 210 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 211 Rest of Europe Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 212 APEJ Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
  • Figure 213 APEJ Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 214 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
  • Figure 215 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 216 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 217 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 218 APEJ Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 219 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
  • Figure 220 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 221 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 222 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 223 APEJ Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 224 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
  • Figure 225 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 226 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 227 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 228 APEJ Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 229 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 230 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 231 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 232 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 233 China Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 234 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 235 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 236 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 237 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 238 Australia Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 239 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 240 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 241 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 242 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 243 India Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 244 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 245 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 246 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 247 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 248 Singapore Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 249 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 250 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 251 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 252 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 253 South Korea Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 254 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 255 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 256 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 257 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 258 Thailand Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 259 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 260 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 261 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 262 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 263 Rest of APEJ Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 264 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
  • Figure 265 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 266 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 267 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 268 Japan Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 269 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
  • Figure 270 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 271 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 272 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 273 Japan Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 274 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
  • Figure 275 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 276 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 277 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 278 Japan Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 279 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 280 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 281 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 282 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 283 Japan Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 284 Latin America Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
  • Figure 285 Latin America Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 286 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
  • Figure 287 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 288 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 289 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 290 Latin America Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 291 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
  • Figure 292 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 293 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 294 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 295 Latin America Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 296 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
  • Figure 297 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 298 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 299 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 300 Latin America Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 301 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 302 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 303 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 304 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 305 Brazil Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 306 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 307 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 308 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 309 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 310 Mexico Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 311 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 312 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 313 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 314 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 315 Argentina Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 316 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 317 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 318 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 319 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 320 Rest of Latin America Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 321 MEA Cancer Diagnostics Market Forecast by Country 2021-2031 (US$ million)
  • Figure 322 MEA Cancer Diagnostics Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 323 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%)
  • Figure 324 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 325 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 326 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 327 MEA Cancer Diagnostics Market Forecast by Test Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 328 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%)
  • Figure 329 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 330 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 331 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 332 MEA Cancer Diagnostics Market Forecast by Cancer Type, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 333 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%)
  • Figure 334 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 335 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 336 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 337 MEA Cancer Diagnostics Market Forecast by End-User, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 338 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 339 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 340 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 341 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 342 GCC Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 343 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 344 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 345 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 346 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 347 South Africa Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 348 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 349 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 350 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 351 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 352 Rest of MEA Cancer Diagnostics Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 353 F. Hoffmann-La Roche Ltd.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 354 F. Hoffmann-La Roche Ltd.: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 355 F. Hoffmann-La Roche Ltd.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 356 F. Hoffmann-La Roche Ltd.: Regional Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 357 F. Hoffmann-La Roche Ltd.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 358 SWOT Analysis
  • Figure 359 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 360 Thermo Fisher Scientific Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 361 Thermo Fisher Scientific Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 362 Thermo Fisher Scientific Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 363 Thermo Fisher Scientific Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
  • Figure 364 SWOT Analysis
  • Figure 365 Siemens AG: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 366 Siemens AG: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 367 Siemens AG: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 368 Siemens AG: Regional Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 369 Siemens AG: EBDITA, 2015-2019 (US$ million, AGR%)
  • Figure 370 SWOT Analysis
  • Figure 371 Bio Rad Laboratories Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 372 Bio Rad Laboratories Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 373 Bio Rad Laboratories Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 374 Bio Rad Laboratories Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 375 Bio Rad Laboratories Inc.: Regional Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 376 SWOT Analysis
  • Figure 377 GE Healthcare: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 378 GE Healthcare: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 379 GE Healthcare: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 380 GE Healthcare: Regional Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 381 SWOT Analysis
  • Figure 382 Illumina, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 383 Illumina, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 384 Illumina, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 385 Illumina, Inc.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 386 Illumina, Inc.: Regional Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 387 SWOT Analysis
  • Figure 388 Koninklijke Philips N.V.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 389 Koninklijke Philips N.V.: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 390 Koninklijke Philips N.V.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 391 Koninklijke Philips N.V.: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 392 SWOT Analysis
  • Figure 393 Canon Medical Systems Corporation: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 394 Canon Medical Systems Corporation: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 395 Canon Medical Systems Corporation: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 396 Canon Medical Systems Corporation: EBDITA, 2015-2019 (US$ million, AGR%)
  • Figure 397 Agilent Technologies, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 398 Agilent Technologies, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 399 Agilent Technologies, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 400 Agilent Technologies, Inc.: Net Income, 2015-2019 (US$ million, AGR%)
  • Figure 401 Agilent Technologies, Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
  • Figure 402 SWOT Analysis
  • Figure 403 Quest Diagnostics: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 404 Quest Diagnostics: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 405 Quest Diagnostics: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 406 Quest Diagnostics: Net Income, 2015-2019 (US$ million, AGR%)
  • Figure 407 Quest Diagnostics: EBDITA, 2015-2019 (US$ million, AGR%)
  • Figure 408 SWOT Analysis
  • Figure 409 Genomic Health (Exact Sciences Corporation): Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 410 Genomic Health (Exact Sciences Corporation): R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 411 Genomic Health (Exact Sciences Corporation): Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 412 Genomic Health (Exact Sciences Corporation): EBDITA, 2015-2019 (US$ million, AGR%)
  • Figure 413 BioMark Diagnostics Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 414 BioMark Diagnostics Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 415 BioMark Diagnostics Inc.: EBDITA, 2015-2019 (US$ million, AGR%)
  • Figure 416 Hologic, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 417 Hologic, Inc.: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 418 Hologic, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 419 Abbott: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 420 Abbott: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 421 Abbott: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 422 Abbott: Net Income, 2015-2019 (US$ million, AGR%)
  • Figure 423 Abbott: Business Segment Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 424 SWOT Analysis
  • Figure 425 BD: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 426 BD: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 427 BD: Gross Profit, 2015-2019 (US$ million, AGR%)
  • Figure 428 BD: Business Segment Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 429 BD: Regional Revenue, 2015-2019 (US$ billion, AGR%)
  • Figure 430 QIAGEN: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 431 QIAGEN: R&D Expenses, 2015-2019 (US$ million, AGR%)
  • Figure 432 QIAGEN: Gross Profit, 2015-2019 (US$ million, AGR%)

Companies Profiled in the Report:

  • Abbott
  • Agilent Technologies, Inc.
  • BD
  • Bio Rad Laboratories Inc.
  • BioMark Diagnostics Inc.
  • Canon Medical Systems Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Genomic Health (Exact Sciences Corporation)
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • QIAGEN
  • Quest Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • List of Other Companies
  • Abbvie
  • Abz-Pharma GmbH
  • Accord Healthcare Ltd
  • Alexion Pharmaceuticals Inc
  • Amgen
  • Apotex Europe Bv
  • AstraZeneca
  • Berlex Inc
  • Biocon
  • Biogen Inc
  • BioPartners GmbH
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Celltech, UCB.
  • Celltrion Healthcare Hungary Kft.
  • Centocor Ortho Biotech Products LP
  • Chugai Pharmaceutical Co., Ltd
  • Coherus Biosciences
  • Dyax Corp.
  • Genmab A/S
  • Genzyme Corp.
  • Guardant Health
  • Hexal Ag
  • Hospira UK Limited
  • Janssen Biotech Inc
  • Kyowa Hakko Kirin
  • Medarex
  • Medice Arzneimittel Putter GmbH & Co. Kg
  • MedImmune
  • Merck
  • Millennium Pharmaceuticals Inc
  • MSD
  • Mylan
  • Novartis
  • NovImmmune
  • Pfizer
  • Qiagen
  • Ratiopharm GmbH
  • Ratiopharm GmbH
  • Regeneron Pharmaceuticals
  • Roche
  • Samsung Bioepis
  • Sandoz GmbH
  • Sanofi
  • Stada Arzneimittel Ag
  • Sysmex Inostics
  • Taimed Biologics
  • Teva GmbH
  • United Therapeutics Corporation
  • Wyeth Pharmaceuticals

List of Organizations

  • American Cancer Society
  • Angeles Clinic and Research Institute
  • British Columbia Cancer Agency
  • Cancer Research Institute
  • Croatian government
  • Department of Anatomic Pathology and the Department of Medical Oncology
  • Drug Controller General of India
  • European Medicines Agency
  • European Union
  • Food and Drug Administration
  • Government of Romania
  • Hospital Clínic
  • Institut Gustave Roussy (Villejuif, France)
  • National Cancer Institute (NCI)
  • Netherlands Cancer Institute (Amsterdam)
  • Organization for Economic Co-operation and Development
  • Serbian government
  • Spanish National Cancer Research Center (CNIO)
  • The Christie Hospital (NHS Foundation Trust)
  • The Cyclotron Centre Bronowice (CCB)
  • The National Institutes of Health
  • The Paula Stradinja University Hospital
  • United Nations
  • University of Leeds in the United Kingdom
  • University of Texas Southwestern Medical Center
  • World Health Organization